Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress

 

  Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present two posters at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Congress in Valencia, Spain on June 1, 2024.

 
  • Dr. Marcus Maurer, M.D., Professor of Dermatology and Allergy at Charité Universitätsmedizin in Berlin, will present information on ALPHA-SOLAR, a long-term open-label trial of STAR-0215 in people living with HAE, in a poster titled "Rationale and Design of the ALPHA-SOLAR Clinical Trial of STAR-0215 for the Treatment of Hereditary Angioedema (HAE)." The poster session will take place on Saturday, June 1 at 12:00pm CEST.
  •  
  • Nikos Biris, Ph.D., Senior Director of Assay Development at Astria Therapeutics, will present information on the characterization of STAR-0310 in a poster titled "Development and Characterization of STAR-0310: a Novel OX40 Antagonistic Monoclonal Antibody." The poster session will take place on Saturday, June 1 at 12:00pm CEST.
  •  

  About Astria Therapeutics:  

 

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema. Our second program, STAR-0310, is a monoclonal antibody OX40 antagonist in preclinical development for the treatment of atopic dermatitis. Learn more about our company on our website, www.astriatx.com , or follow us on X and Instagram @AstriaTx and on Facebook and LinkedIn.

 

  

  

  Astria Contact:  
Investor Relations and Media:  
Elizabeth Higgins
investors@astriatx.com  

 

News Provided by Business Wire via QuoteMedia

ATXS:US
The Conversation (0)
Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference

Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference

 

  Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Jefferies Healthcare Conference on Thursday, June 6 th at 10:00am ET in New York, NY.

 

A webcast of the presentation can be accessed at the following link: https://wsw.com/webcast/jeff302/atxs/1868288 . An archived replay of the presentation will be available in the investors section of www.astriatx.com for 30 days following the event.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Astria Therapeutics to Present at Upcoming Eastern Allergy Conference

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference

 

  Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present final STAR-0215 Phase 1a healthy subject data in an encore presentation at the upcoming Eastern Allergy Conference in Palm Beach, Florida on June 1, 2024.

 

Jessica Best, Vice President of Medical Affairs at Astria Therapeutics, will present a poster titled, "Updated Results of a Phase 1a Trial of STAR-0215 for Hereditary Angioedema" at 9:45am EST on Saturday, June 1.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635

 

  Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase 173,500 shares of Astria's common stock on May 1, 2024 under Astria's 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria.

 

The options were granted as an inducement material to four employees entering into employment with Astria in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $9.50 which is equal to the closing price of Astria's common stock on May 1, 2024 (the "Grant Date"), and will vest over a four-year period, with 25% of shares vesting on the first anniversary of the employee's employment start date (which preceded the Grant Date) and the remaining shares vesting monthly on a ratable basis over the following 36 months, subject to the employee's continued employment with Astria on such vesting dates. The options are subject to the terms and conditions of the 2022 Inducement Stock Incentive Plan and the terms and conditions of an award agreement covering the grant.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Vertex Minerals Limited  Quarterly Activities Report

Vertex Minerals Limited Quarterly Activities Report

Perth, Australia (ABN Newswire) - Vertex Minerals Limited (ASX:VTX,OTC:VTXXF) (OTCMKTS:VTXXF), is pleased to provide a summary of its activities for the quarter ended 30 June 2025.

HIGHLIGHTS FOR QUARTER

- Commencement of operations at the Reward Gold Mine Gravity plant, with processing of low-grade stockpiled gold ore through the gravity gold plant undertaken throughout the quarter, producing saleable gold.

- During the quarter, Vertex remained focused on moving the business to be operationally ready for underground mining at the Reward gold mine.

- VTX remainsfirmly on track to deliver first underground high grade gold ore to the Gravity Gold plant in Q3 2025, with commissioning and underground mine readiness ramp-up activities progressing as planned.

- VTX's Technical Services team has identified a fully developed stope block to include in the mine production start-up.

o Stopes are suitable for airleg mining which will augment jumbo production.

o Stope blocks contain an Inferred Resource of 2,075 tonnes at 17.8 g/t Au and forms part of the 2023 Mineral Resource Estimate. With the lower block having over 700 tonnes at 42.5 g/t. The planned stope width is the same as the interpretation of the mineralisation

- Key management hires, with staff procurement complete for on-site field team:

o Appointment of Mr Vince Fayad and Mr Kurt Laney as Joint CFOs

o Appointment of Mr Ian Morgan as Company Secretary

o Specialist on-site technical services team now fully onboarded

- Firm commitments received to raise approximately A$11 million via a combination of share placement and convertible note issuance to institutional and sophisticated investors.

- Vertex registered office and principal place of business changed to the following address: 6 Bowen St, Hill End, NSW, 2850.

- Vertex will run the mine, drill equipment and the processing plant as an owner operator. Gold Underground Mining Readiness

- First phase of underground specialist miners onboarded under owner operator model

o TD1 Jumbo Drill fully operational and operating underground

o Primary ventilation installed

o First stope development dewatering completed

o Explosive Magazine constructed

o Water feed installed

o Air lines installed and operational -

o 11kva power installation underway

o Jumbo boxes on site

- Revised mine plan and schedule completed and ready to implement.

- Pulse Mining System installed and implemented.

- Underground Ore trialled through gravity plant

o The underground miners have trialled a batch of 90 ton of development material with some reef quartz through the gravity plant with throughput exceeding expectation and beyond the nameplate plant flow sheet value.

- INX Software Installed and Implemented

o INX Software and site access kiosks to go live at mine site in August.

o INX will improve safety framework with real time incident and injury reporting system.

o Strengthens site access controls for employees, contractors and visitors to site.

- Sand Stack facility fully operational

o Facility fully functioning with return water pump station installed and operational (water recycling)

o 57 Megalitre Turon River water licence purchased for back up water supply

- Environmental & Compliance Implementation

o Multiple real-time monitoring systems installed (dust, noise, vibration)

- Underground Drilling site being established

o Drill Cuddy (room for drill rig) drilled and fired for Vertex Diamond Rig readiness

Improvements to plant

- DSM screen installed

- Gemini table improvements with new top and gearbox

- Process water pump upgrade

- Treating of underground rock has shown higher plant throughput

Vertex Minerals Executive Chairman, Roger Jackson, commented:

"We are pleased to present our Activities Report for the June quarter - another busy period where our team worked seamlessly to coordinate the many moving parts involved in the redevelopment of the high-grade Reward mine and associated processing facilities. During the quarter, Vertex delivered on another round of key operational milestones for both mine optimisation and improvements to the processing plant. With the completion of these initiatives, Vertex is now positioned to execute on our stated objective to recommence underground mining in August, underpinning our transition to high-grade gold production."

"Reflecting investor confidence in our development strategy, we were also pleased to complete a successful $11m capital raise during the quarter, which leaves the Company well funded to finalise all pre-development works for mining and processing, and fully unlock the value of this asset. As we head into the September quarter, I'm thrilled to be working as part of a really strong team, all of whom are committed to the execution of our stated development strategy. We look forward to providing more updates in the coming months and mining and production gets underway."

*To view the full Quarterly Report, please visit:
https://abnnewswire.net/lnk/YA65USAA

 

About Vertex Minerals Limited:  

Vertex Minerals Limited (ASX:VTX,OTC:VTXXF) is an Australian based gold exploration company developing its advanced Hargraves and Hill End gold projects located in the highly prospective Eastern Lachlan Fold Belt of Central West NSW. Other Company assets include the Pride of Elvire gold project and Taylors Rock gold/nickel/lithium project both located in the Eastern Goldfields of WA. The focus of Vertex Minerals is to advance the commercial production of gold from its NSW projects embracing an ethical and environmentally sustainable approach.

 

 

Source:
Vertex Minerals Limited

News Provided by ABN Newswire via QuoteMedia

Keep reading...Show less
Prismo Metals Announces Closing of Private Placement and Further Upsizing

Prismo Metals Announces Closing of Private Placement and Further Upsizing

 

(TheNewswire)

 
       
  Prismo Metals Inc. 
                
 

Vancouver, British Columbia, July 31st, 2025 TheNewswire - Prismo Metals Inc. (" Prismo " or the " Company ") (CSE: PRIZ,OTC:PMOMF) (OTCQB: PMOMF) is pleased to announce that further to its news releases dated July 3, 2025 and July 18, 2025, the Company has proceeded with an upsized second closing of its previously announced non-brokered private placement of units of the Company (" Units ") at an issue price of $0.05 per Unit (the "Private Placement" ). The second closing of the Private Placement was increased from 2,000,000 Units to the issuance of 2,340,000 Units for gross proceeds of $117,000. The Company previously announced a first closing of the Private Placement on July 18, 2025 for aggregate gross proceeds of $575,000. Due to strong investor demand, the Company has now raised aggregate gross proceeds of $692,000 through the sale of an aggregate of 13,840,000 Units.

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
Group Eleven Closes C$5.75M Bought Deal Private Placement, Including Full Exercise of C$750,000 Underwriters' Option

Group Eleven Closes C$5.75M Bought Deal Private Placement, Including Full Exercise of C$750,000 Underwriters' Option

Group Eleven Resources Corp. (TSXV: ZNG,OTC:GRLVF) (OTCQB: GRLVF) (FSE: 3GE) (the "Company") is pleased to announce the closing of its previously-announced "bought deal" private placement for aggregate gross proceeds of C$5,750,000 (the "Offering") through the issuance of 17,968,750 common shares of the Company (the "Common Shares") at a price of C$0.32 per Common Share. The Offering was completed pursuant to an underwriting agreement between the Company, and Cormark Securities Inc. and Beacon Securities Limited (together, the "Underwriters") and included the full exercise of the Underwriters' option.

The Company intends to use the net proceeds from the Offering to expand the remaining funded exploration drill program at Ballywire from approximately 5,000m to approximately 25,000m, and for working capital and general corporate purposes.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×